• Marcia HogelingEmail author


Childhood vasculitis includes a challenging group of conditions that often require multi-specialty care by dermatology, rheumatology, nephrology, cardiology, neurology, gastroenterology, and general pediatrics. Vasculitis in children may be from infection, autoimmune disorders, drug induced, related to malignancy, or idiopathic. A skin biopsy is essential for the diagnosis of many types of vasculitis. The most common type of childhood vasculitis is Henoch–Schönlein Purpura. This chapter discusses several types of pediatric vasculitis including Henoch–Schönlein Purpura, Polyarteritis nodosa, and Acute Hemorrhagic Edema of Infancy.


Vasculitis Leukocytoclastic vasculitis Panniculitis Polyarteritis nodosa Henoch–Schönlein Purpura Acute hemorrhagic edema of infancy 


  1. 1.
    Ting TV. Diagnosis and management of cutaneous vasculitis in children. Pediatr Clin North Am. 2014;61(2):321–46.CrossRefPubMedGoogle Scholar
  2. 2.
    Williams VL, Guirola R, Flemming K, et al. Distal extremity necrosis as a manifestation of cutaneous polyarteritis nodosa; case report and review of the acute management of a pediatric patient. Pediatr Dermatol. 2012;29(4):473–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Merlin E, Mouy R, Pereira B, Mouthon L, et al. Long term outcome of children with pediatric onset cutaneous and visceral polyarteritis nodosa. Joint Bone Spine. 2015;10(3):e0120981.Google Scholar
  4. 4.
    Zoshima T, Matsumura M, Suzuki Y, et al. A case of refractory cutaneous polyarteritis nodosa in a patient with hepatitis B carrier status successfully treated with tumor necrosis factor alpha blockade. Mod Rheumatol. 2013;23(5):1029–33.CrossRefPubMedGoogle Scholar
  5. 5.
    Schartz NE, Alaoui S, Vignon-Pennamen MD, et al. Successful treatment in two cases of steroid-dependent cutaneous polyarteritis nodosa with low-dose methotrexate. Dermatology. 2001;203(4):336–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Lobo I, Ferreira M, Silva E, et al. Cutaneous polyarteritis nodosa treated with intravenous immunoglobulins. J Eur Acad Dermatol Venereol. 2008;22(7):880–2.CrossRefPubMedGoogle Scholar
  7. 7.
    Kluger N, Guillot B, Bessis D. Ulcerative cutaneous polyarteritis nodosa treated with mycophenolate mofetil and pentoxifylline. J Dermatolog Treat. 2011;22(3):175–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Till SH, Amos RS. Long-term follow-up of juvenile-onset cutaneous polyarteritis nodosa associated with streptococcal infection. Br J Rheumatol. 1997;36(8):909–11.CrossRefPubMedGoogle Scholar
  9. 9.
    Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Schonlein purpura in an unselected childhood population. Eur J Pediatr. 1988;147:113–5.CrossRefPubMedGoogle Scholar
  10. 10.
    den Boer SL, Pasmans SG, Wulffraat NM, Ramakers-Van Woerden NL, Bousema MT. Bullous lesions in Henoch Schönlein Purpura as indication to start systemic prednisone. Acta Paediatr. 2010;99(5):781–3. doi: 10.1111/j.1651-2227.2009.01650.x. Epub 2009 Jan 5.CrossRefGoogle Scholar
  11. 11.
    Chan KH, Tang WY, Lo KK. Bullous lesions in Henoch-Schönlein purpura. Pediatr Dermatol. 2007;24(3):325–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Savino F, Lupica MM, Tarasco V, et al. Acute hemorrhagic edema of infancy: a troubling cutaneous presentation with a self limiting course. Pediatr Dermatol. 2013;30(6):3149–52.CrossRefGoogle Scholar
  13. 13.
    Fiore E, Rizzi M, Ragazzi M, et al. Acute hemorrhagic edema of young children (cockade purpura and edema); a case series and systematic review. J Am Acad Dermatol. 2008;59(4):684–95.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Division of DermatologyUniversity of California, Los AngelesLos AngelesUSA

Personalised recommendations